MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 242, 35-40
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- Johnson & Johnson Innovative Medicine
This publication has 15 references indexed in Scilit:
- MYCamplifications in myeloma cell lines: correlation with MYC-inhibitor efficacyOncotarget, 2015
- Disappearance of double minute chromosomes with MYC amplification in relapsed acute myeloid leukemia after stem cell transplantationInternational Journal of Hematology, 2015
- 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemiaJournal of Hematology & Oncology, 2014
- Chromosome 8q24.1/c-MYCabnormality: a marker for high-risk myelomaLeukemia & Lymphoma, 2014
- Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patientsBlood Cancer Journal, 2014
- The impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapyInternational Journal of Hematology, 2014
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupLeukemia, 2012
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Frequent upregulation of MYC in plasma cell leukemiaGenes, Chromosomes and Cancer, 2009
- MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target geneHuman Molecular Genetics, 2006